SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0000950123-18-006751
Filing Date
2018-07-11
Accepted
2018-07-11 17:02:01
Documents
13

Document Format Files

Seq Description Document Type Size
1 FORM S-3 vktx-S3_20180711.htm S-3 634285
2 EX-4.10 vktx-ex410_7.htm EX-4.10 415940
3 EX-5.1 vktx-ex51_6.htm EX-5.1 38724
4 EX-12.1 vktx-ex121_32.htm EX-12.1 119494
5 EX-23.1 vktx-ex231_8.htm EX-23.1 3682
6 GRAPHIC g201807112000098523297.jpg GRAPHIC 2494
7 GRAPHIC g201807112000098793298.jpg GRAPHIC 2494
8 GRAPHIC g201807112000098883299.jpg GRAPHIC 2494
9 GRAPHIC g201807112000098973300.jpg GRAPHIC 2494
10 GRAPHIC g201807112000099143301.jpg GRAPHIC 2494
11 GRAPHIC g201807112000099223302.jpg GRAPHIC 2494
12 GRAPHIC g201807112000113931869.jpg GRAPHIC 3305
13 GRAPHIC g201807112000212991870.jpg GRAPHIC 3305
  Complete submission text file 0000950123-18-006751.txt   1244124
Mailing Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130
Business Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130 858-704-4660
Viking Therapeutics, Inc. (Filer) CIK: 0001607678 (see all company filings)

IRS No.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-226133 | Film No.: 18949118
SIC: 2834 Pharmaceutical Preparations